IL6 and COVID-19: Diabetes, especially in the presence of hyperglycemia, significantly influences the severity of COVID-19 symptoms, possibly due to the association between hyperglycemia and elevated levels of IL-6 and IL-6 receptors, indicative of severe lung disease in COVID-19 patients.